Biotron Partners With Medical Data Company Diagnose.me

Analytics platform Biotron.io is partnering with medical data company Diagnose.me to combine their expertise and improve patient care worldwide. This partnership will capitalise on Biotron’s strength in data collection and analytics, and couple it with Diagnose.me’s experience in health diagnostics and research. Biotron has chosen Diagnose.me to be their exclusive partner within the health vertical of their business. This partnership supports their mutual ambition of using data analytics to drive innovation within the healthcare industry.

Biotron’s mission is to solve real-life problems using high-quality data and the expertise and experience that Diagnose.me has perfectly fits this goal. – Peter Dendis – CoFounder of Biotron.io

Thanks to new technologies and companies like Biotron, patients (the data owners) will finally benefit from the use of their medical and health information. They will have complete control over the data and how it is used and be reimbursed each time their personal information assists research and development in the medical industry.

Current State Of Health Care Data

Health records around the world are currently stored by a multitude of medical institutions and data companies, and while this information is sometimes shared, it is limited and problematic. Issues regarding privacy and accessibility make combining and analysing data from multiple sources difficult. As a result, vital information that could contribute to health research greatly lies dormant.

Privacy for patients is paramount within the healthcare industry. Though necessary, privacy implications severely limit the access medical professionals and researchers have to personal records. Accessing information requires express consent, which can be difficult to get, especially in the vast quantities needed for meaningful research.

How Biotron And Blockchain Offer A Single Solution

Biotron’s analytics platform solves the problems surrounding access to medical information. It gives physicians and researchers a resource of health data that comes directly from the people that produce it. Biotron users contribute and upload first-hand information that is timely, accurate and comprehensive. This information is then prepared for sale to customers in the healthcare industry. The global nature of the user base delivers information from across a diverse set of socio-economic and geographical backgrounds.

Privacy implications, usually associated with the use of medical records, are solved thanks to the opt-in nature of the Biotron platform. Users who produce the data, choose to share it via an app or dashboard, in return for payment. This consent can be revoked at any time, and is fully GDPR compliant. All information is pseudonymised when necessary so it cannot be attributed to an individual.

Blockchain technology is used to ensure that the people producing and offering the data are all paid for contributing their health information. It facilitates the transactions between the customers and the many data contributors. Biotron’s solution uses smart contracts to connect customers with data producers and to ensure sure that only authorised access is ever granted to health information.

Plan for 2018

In the first phase of the relationship, Biotron will create an infrastructure for a shared environment and make sure that all records are stored securely and that the legal framework is in place. Next, both partners will start on-boarding users through both Biotron’s and Diagnose.me’s channels. In line with Biotron’s business model, users will all be paid for contributing their data to the analytics products created by the partnership. The first-year goal of the cooperation is to gather data and provide it to relevant partners, such as research organisations.

We are experts in data collection and analytics but we need strong partners to effectively penetrate each industry. Diagnose.me understands the role that data has in driving innovation and their forward-thinking approach make for a strong collaboration. – Pavol Magic – CEO of Biotron.io

About Diagnose.me

Diagnose.me is an online platform connecting patients with top international specialists, hospitals and researchers. They collate and use medical data for the benefit of better diagnostics, research, pharmaceuticals, and even insurance products.

The business also drives medical data to their platform thanks to wearables and applications from users. Diagnose.me uses diagnostic software on the basis of AI to diagnose symptoms that normally cannot be easily measured. The data amassed by Diagnose.me constitutes very complicated patient cases and already saved hundreds of lives.

About Biotron

Biotron is a fully transparent data analytics platform. It gives users control over what data is being collected and how it is used, and provides customers with datasets and data products of unparalleled quality, giving them valuable insights for their businesses. It’s vision is to tear down data silos created by technological giants and enable innovation in various industries.

The post Biotron Partners With Medical Data Company Diagnose.me appeared first on Bitcoin Garden.

Komentar

Posting Komentar

Postingan populer dari blog ini

Transformation of education in post-industrial society

Gambar
Education has always been an expensive privilege; and the education sector has always been one of the most conservative. People chose profession once in their life and did not change it until retirement. Usually education meant studying at a university; self-taught people were rare. However, in the post-industrial society changes in the shape, sense and affordability of education finally began. According to Alvin Toffler, a well-known US sociologist, the emergence of the post-industrial society is a consequence of the intellectual revolution. The possession of knowledge and information will replace financial capital as the biggest value. Development of innovations, empowered by the most educated, will become the most important sector of economy. It means that high-quality affordable education will become even more important than now. The last time when the global education experienced a serious transformation was at the very beginning of the 21st century when the wide access to the I
Baca selengkapnya

Blockchain Supply Chain Forum will be held on January 10th in Hong Kong

Gambar
The concept of a blockchain – a distributed, tamper-proof and time-stamped database of transactions that can be managed without intermediaries – is highly attractive in the supply chain domain, and the industry has launched a number of proof-of-concept initiatives. However, awareness of how blockchains work and what they can accomplish for supply chain is still relatively low. The lack of knowledge is exacerbated by the fast pace at which the technology is evolving. A success Blockchain Supply Chain Forum was held on October 24th in Shanghai, professional blockchain organizer EventLinker and Global Supply Chain Council will organize the Blockchain Supply Chain Forum on January 10th in Hong Kong, it is the forum connecting blockchain experts, supply chain and logistics decision makers and tech innovators. This intimate gathering will explore how companies are investigating the use and deployment of the technology to help their supply chains in China. Organizer: EventLinker EventLin
Baca selengkapnya

After GDPR effect? In A Post Cookie World, Blockchain Is Rising

Gambar
The European General Data Protection Regulation (GDPR) was rolled out in May this year. It introduced far-reaching implications for companies which process personal data related to EU citizens. Even those far outside the EU could not fail to notice this change. Email inboxes were overflowing with opt-out reminders. Cookie banners now obscure many websites, forcing users to agree to a privacy policy so that they can browse the content on the site. Although the GDPR document itself clocks in at 88 pages, the majority of what it covers can be summed up in one word — consent. If companies are processing personal data, it must be done with the explicit, informed consent of the individual. For some forms of marketing, such as email subscriber lists, this involved minimal changes. Individuals already have to take the active step of providing their email addresses, and usually it is pretty clear why they are asked to do so. However, for the digital advertising industry, consent is far less
Baca selengkapnya